X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2817) 2817
Publication (238) 238
Book Review (36) 36
Newsletter (28) 28
Book Chapter (14) 14
Book / eBook (7) 7
Conference Proceeding (6) 6
Magazine Article (6) 6
Reference (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2062) 2062
male (1416) 1416
female (1083) 1083
animals (1014) 1014
bronchodilator agents - pharmacology (991) 991
bronchodilator agents - administration & dosage (885) 885
bronchodilator agents - therapeutic use (870) 870
index medicus (867) 867
asthma (817) 817
asthma - drug therapy (793) 793
pharmacology & pharmacy (737) 737
respiratory system (672) 672
adult (659) 659
administration, inhalation (648) 648
middle aged (538) 538
bronchodilator agents - pharmacokinetics (406) 406
aged (332) 332
pulmonary disease, chronic obstructive - drug therapy (327) 327
asthma - physiopathology (314) 314
rats (307) 307
dose-response relationship, drug (302) 302
asthma - metabolism (294) 294
guinea pigs (285) 285
lung - metabolism (278) 278
bronchodilator agents - adverse effects (271) 271
adolescent (269) 269
child (269) 269
in vitro techniques (253) 253
double-blind method (242) 242
inflammation (231) 231
obstructive pulmonary-disease (224) 224
treatment outcome (224) 224
copd (215) 215
lung - drug effects (213) 213
bronchodilator agents (212) 212
theophylline (212) 212
pharmacokinetics (208) 208
bronchodilator agents - metabolism (201) 201
cross-over studies (198) 198
corticosteroids (197) 197
budesonide (194) 194
drug therapy (194) 194
albuterol - administration & dosage (193) 193
time factors (192) 192
muscle, smooth - drug effects (191) 191
allergy (186) 186
lung diseases, obstructive (175) 175
immunology (174) 174
aerosols (173) 173
chronic obstructive pulmonary disease (173) 173
albuterol - pharmacology (171) 171
drug therapy, combination (168) 168
trachea - drug effects (167) 167
research (165) 165
fluticasone (164) 164
analysis (160) 160
bronchi - drug effects (160) 160
mice (159) 159
bronchodilator (151) 151
albuterol - therapeutic use (148) 148
nebulizers and vaporizers (147) 147
adrenergic beta-agonists - pharmacology (146) 146
formoterol fumarate (145) 145
care and treatment (144) 144
respiratory function tests (143) 143
children (142) 142
bronchodilator agents - blood (137) 137
bronchoconstriction - drug effects (136) 136
bronchodilators (136) 136
salbutamol (136) 136
pulmonary disease, chronic obstructive - physiopathology (135) 135
nitric oxide (133) 133
child, preschool (132) 132
respiratory tract diseases (132) 132
administration, oral (129) 129
theophylline - pharmacology (129) 129
budesonide - administration & dosage (128) 128
health aspects (128) 128
salmeterol (127) 127
forced expiratory volume - drug effects (126) 126
theophylline - administration & dosage (126) 126
pulmonary disease, chronic obstructive - metabolism (124) 124
inhalation (122) 122
pediatrics (122) 122
physiology (120) 120
adrenal cortex hormones - therapeutic use (119) 119
bronchodilator agents - chemistry (118) 118
cells, cultured (118) 118
drug combinations (118) 118
albuterol (117) 117
isoproterenol - pharmacology (117) 117
nitric oxide - metabolism (116) 116
albuterol - analogs & derivatives (115) 115
theophylline - pharmacokinetics (115) 115
forced expiratory volume (114) 114
anti-inflammatory agents - therapeutic use (112) 112
theophylline - therapeutic use (112) 112
anti-asthmatic agents - therapeutic use (111) 111
drug interactions (111) 111
in-vitro (110) 110
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2743) 2743
Japanese (48) 48
German (25) 25
French (19) 19
Russian (17) 17
Chinese (15) 15
Polish (10) 10
Spanish (8) 8
Italian (7) 7
Dutch (4) 4
Danish (3) 3
Romanian (3) 3
Croatian (1) 1
Hebrew (1) 1
Norwegian (1) 1
Swedish (1) 1
Turkish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Pharmacology & Therapeutics, ISSN 0009-9236, 07/2018, Volume 104, Issue 1, pp. 188 - 200
The accuracy of physiologically based pharmacokinetic (PBPK) model prediction in children, especially those younger than 2 years old, has not been... 
CLEARANCE | TISSUE DISTRIBUTION | IN-VIVO | VOLUME | ONTOGENY | PROTON PUMP INHIBITORS | PHARMACOLOGY & PHARMACY | PHARMACODYNAMICS | SIMULATION | DESLORATADINE | EXPOSURE | Humans | Anti-Asthmatic Agents - metabolism | Child, Preschool | Cytochrome P-450 Enzyme System - metabolism | Sufentanil - metabolism | Bronchodilator Agents - metabolism | Quinolines - pharmacokinetics | Theophylline - pharmacokinetics | Esomeprazole - metabolism | Anti-Inflammatory Agents, Non-Steroidal - metabolism | Ondansetron - metabolism | Child | Cytochrome P-450 CYP2C9 - metabolism | Histamine H1 Antagonists, Non-Sedating - pharmacokinetics | Infant, Newborn | Itraconazole - metabolism | Serotonin Antagonists - pharmacokinetics | Tramadol - pharmacokinetics | Theophylline - metabolism | Cytochrome P-450 CYP3A - metabolism | Models, Biological | Proton Pump Inhibitors - metabolism | Anti-Inflammatory Agents, Non-Steroidal - pharmacokinetics | Cytochrome P-450 CYP2D6 - metabolism | Serotonin Antagonists - metabolism | Analgesics, Opioid - metabolism | Diclofenac - metabolism | Lansoprazole - pharmacokinetics | Loratadine - pharmacokinetics | Sufentanil - pharmacokinetics | Infant | Anti-Asthmatic Agents - pharmacokinetics | Itraconazole - pharmacokinetics | Antifungal Agents - pharmacokinetics | Antifungal Agents - metabolism | Loratadine - metabolism | Cytochrome P-450 CYP2C8 - metabolism | Lansoprazole - metabolism | Acetates - metabolism | Esomeprazole - pharmacokinetics | Cytochrome P-450 CYP1A2 - metabolism | Ondansetron - pharmacokinetics | Tramadol - metabolism | Diclofenac - pharmacokinetics | Quinolines - metabolism | Pharmaceutical Preparations - metabolism | Proton Pump Inhibitors - pharmacokinetics | Bronchodilator Agents - pharmacokinetics | Analgesics, Opioid - pharmacokinetics | Cytochrome P-450 CYP2C19 - metabolism | Loratadine - analogs & derivatives | Histamine H1 Antagonists, Non-Sedating - metabolism | Pharmacokinetics | Acetates - pharmacokinetics
Journal Article
Journal Article
International Journal of Pharmaceutics, ISSN 0378-5173, 04/2012, Volume 426, Issue 1-2, pp. 7 - 14
A physiologically pertinent model is urgently needed for probing interactions between inhaled drugs and the organic cation transporters (OCT) in the bronchial... 
Carrier-mediated transport | Bronchial epithelium | In vitro models | Calu-3 cells | Organic cation transporters | Permeability | Pulmonary absorption | ABC | BRONCHIAL EPITHELIAL-CELLS | CULTURE | DISPOSITION | DELIVERY | MODELS | PHARMACOLOGY & PHARMACY | ABSORPTION | Ethanolamines - pharmacology | Formoterol Fumarate | Epithelial Cells - metabolism | Respiratory Mucosa - drug effects | Bronchodilator Agents - administration & dosage | Albuterol - pharmacology | Epithelial Cells - drug effects | Humans | Fluorescent Dyes - metabolism | Organic Cation Transporter 1 - metabolism | Bronchodilator Agents - metabolism | Organic Cation Transporter 2 | Dose-Response Relationship, Drug | Solute Carrier Family 22 Member 5 | Organic Cation Transport Proteins - antagonists & inhibitors | Biological Transport | Organic Cation Transport Proteins - drug effects | Cell Line | Organic Cation Transport Proteins - metabolism | Gene Expression Regulation | Administration, Inhalation | Bronchodilator Agents - pharmacology | Ipratropium - pharmacology | Budesonide - pharmacology | Ethanolamines - metabolism | Organic Cation Transporter 1 - antagonists & inhibitors | Respiratory Mucosa - metabolism | Organic Cation Transport Proteins - genetics | Pyridinium Compounds - metabolism | Phosphates | Complications and side effects | Tissue engineering | Analysis | Drug interactions | Fluorescein | DNA polymerases | Respiratory agents | Investigations | Cells
Journal Article
Pharmaceutical Research, ISSN 0724-8741, 6/2012, Volume 29, Issue 6, pp. 1670 - 1688
Journal Article
Journal of Aerosol Medicine and Pulmonary Drug Delivery, ISSN 1941-2711, 04/2016, Volume 29, Issue 2, pp. 127 - 133
Journal Article
Analytical and Bioanalytical Chemistry, ISSN 1618-2642, 9/2016, Volume 408, Issue 24, pp. 6789 - 6797
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 03/2006, Volume 533, Issue 1-3, pp. 182 - 194
Chronic inflammatory airway diseases such as bronchial asthma or chronic obstructive pulmonary disease (COPD) are major contributors to the global burden of... 
VIP | Tachykinin | Lung | Cytokine | cytokine | CYCLASE-ACTIVATING POLYPEPTIDE | GENE-RELATED PEPTIDE | ISOLATED HUMAN AIRWAYS | PEPTIDE TRANSPORTER PEPT2 | IN-VIVO BRONCHODILATOR | HUMAN NASAL-MUCOSA | tachykinin | lung | HISTAMINE-INDUCED BRONCHOCONSTRICTION | OBSTRUCTIVE PULMONARY-DISEASE | PHARMACOLOGY & PHARMACY | SMOOTH-MUSCLE RELAXATION | GUINEA-PIG TRACHEA | Bronchodilator Agents - therapeutic use | Vasoactive Intestinal Peptide - metabolism | Asthma - metabolism | Lung - innervation | Respiratory Mucosa - drug effects | Humans | Bronchodilator Agents - metabolism | Receptors, Vasoactive Intestinal Peptide - chemistry | Vasodilation | Receptors, Vasoactive Intestinal Peptide - metabolism | T-Lymphocytes - metabolism | Vasoactive Intestinal Peptide - pharmacology | T-Lymphocytes - drug effects | Neuropeptides - pharmacology | Lung - metabolism | Vasoactive Intestinal Peptide - therapeutic use | Vagus Nerve - metabolism | Bronchodilator Agents - pharmacology | Mucus - secretion | Neuropeptides - metabolism | Receptors, Vasoactive Intestinal Peptide - drug effects | Asthma - drug therapy | Neuropeptides - therapeutic use | Randomized Controlled Trials as Topic | Animals | Lung - drug effects | Pituitary Adenylate Cyclase-Activating Polypeptide - metabolism | Protein Conformation | Respiratory Mucosa - metabolism | Lung - blood supply | Medical colleges | Respiratory agents | Polypeptides | Drug therapy | Peptide hormones | Asthma
Journal Article